Apollo Medical Holdings, Inc., a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. The company serves the patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organizations; and non-insured patients in California. Apollo Medical Holdings, Inc. was founded in 1994 and is headquartered in Alhambra, California.
Industry, Sector and Symbol
Industry Management consulting services
Sub-IndustryN/A
SectorMedical
Phone626-282-0288
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$519.91 million
Profitability
Miscellaneous
Employees475
Next Earnings Date3/16/2020 (Estimated)
OptionableNot Optionable
Apollo Medical (NASDAQ:AMEH) Frequently Asked Questions
What is Apollo Medical's stock symbol?
Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."
How were Apollo Medical's earnings last quarter?
Apollo Medical Holdings Inc (NASDAQ:AMEH) issued its quarterly earnings results on Thursday, November, 7th. The company reported $0.14 earnings per share for the quarter, hitting the consensus estimate of $0.14. The business earned $156.06 million during the quarter. Apollo Medical had a return on equity of 3.16% and a net margin of 0.88%. View Apollo Medical's Earnings History.
When is Apollo Medical's next earnings date?
Has Apollo Medical been receiving favorable news coverage?
Media coverage about AMEH stock has been trending very negative recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Apollo Medical earned a news impact score of -3.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Apollo Medical.
Are investors shorting Apollo Medical?
Apollo Medical saw a decline in short interest in January. As of January 15th, there was short interest totalling 872,600 shares, a decline of 23.5% from the December 31st total of 1,140,000 shares. Based on an average trading volume of 126,800 shares, the days-to-cover ratio is presently 6.9 days. Approximately 10.1% of the shares of the stock are short sold. View Apollo Medical's Current Options Chain.
Who are some of Apollo Medical's key competitors?
Some companies that are related to Apollo Medical include ICF International (ICFI), Huron Consulting Group (HURN), NIC (EGOV), RMR Group (RMR), The Hackett Group (HCKT), Blackrock Capital Investment (BKCC), Information Services Group (III), Avalon Globocare (AVCO), Gopher Protocol (GOPH), ATIF (ATIF), TSS (TSSI), Wilhelmina International (WHLM), Pharma Bio Serv (PBSV), Lightbridge (LTBR) and Digipath (DIGP).
What other stocks do shareholders of Apollo Medical own?
Who are Apollo Medical's key executives?
Apollo Medical's management team includes the folowing people:
- Dr. Kenneth T. Sim M.D., Exec. Chairman
- Dr. Thomas S. Lam, CEO & Director (Age 70)
- Mr. Eric Chin, Chief Financial Officer
- Mr. Hing Ang, Chief Operating Officer
- Dr. Albert Young M.D., Co-Chief Medical Officer
Who are Apollo Medical's major shareholders?
Apollo Medical's stock is owned by many different of institutional and retail investors. Top institutional investors include Virginia Retirement Systems ET AL (0.17%) and Zurcher Kantonalbank Zurich Cantonalbank (0.01%). Company insiders that own Apollo Medical stock include Adrian Vazquez, Albert Waichow Young, Eric Chin, John Chiang, Kenneth T Sim, Mark Fawcett, Michael F Eng, Physicians Of Californi Allied, Thomas S Lam and Warren Hosseinion. View Institutional Ownership Trends for Apollo Medical.
Which institutional investors are buying Apollo Medical stock?
AMEH stock was bought by a variety of institutional investors in the last quarter, including Virginia Retirement Systems ET AL and Zurcher Kantonalbank Zurich Cantonalbank . Company insiders that have bought Apollo Medical stock in the last two years include Albert Waichow Young, Eric Chin, John Chiang, Kenneth T Sim, Mark Fawcett, Michael F Eng, Physicians Of Californi Allied and Thomas S Lam. View Insider Buying and Selling for Apollo Medical.
How do I buy shares of Apollo Medical?
Shares of AMEH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Apollo Medical's stock price today?
One share of AMEH stock can currently be purchased for approximately $18.31.
How big of a company is Apollo Medical?
Apollo Medical has a market capitalization of $638.84 million and generates $519.91 million in revenue each year. The company earns $10.84 million in net income (profit) each year or $0.29 on an earnings per share basis. Apollo Medical employs 475 workers across the globe.View Additional Information About Apollo Medical.
What is Apollo Medical's official website?
How can I contact Apollo Medical?
Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The company can be reached via phone at 626-282-0288 or via email at [email protected]
MarketBeat Community Rating for Apollo Medical (NASDAQ AMEH)
MarketBeat's community ratings are surveys of what our community members think about Apollo Medical and other stocks. Vote "Outperform" if you believe AMEH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMEH will underperform the S&P 500 over the long term. You may vote once every thirty days.
